Literature DB >> 11478920

NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusion.

Y Liu1, G Zhang, C Gao, X Hou.   

Abstract

Transient ischemia increases tyrosine phosphorylation of N-methyl-D-aspartate (NMDA) receptor. Several tyrosine kinases are involved in this process. In this study, effect of ischemia and reperfusion (I/R) on tyrosine phosphorylation of NMDA receptor subunit 2A (NR2A) and the interaction of two tyrosine kinases, Src and Pyk2, with NR2A was investigated. Four-vessel occlusion was used to produce transient (15 min) cerebral ischemia in SD rats. Tyrosine phosphorylation of NR2A in hippocampus was enhanced after 15 min of reperfusion and reached its peak level at 6 h of reperfusion. The increase sustained for at least 24 h. Src and Pyk2 co-immunoprecipitated with NR2A and the binding increased after I/R, which also reached a peak at 6 h of reperfusion. Besides, Src and Pyk2 were activated after I/R. These increases were prevented by ketamine, a selective NMDA receptor antagonist, which was administered to the SD rats 20 min before ischemia. Moreover, Src and Pyk2 coprecipitated with each other. These data show that NR2A, Src and Pyk2 might form a protein complex in vivo and the interaction suggests a possible mechanism of signal transduction in the postischemic hippocampus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478920     DOI: 10.1016/s0006-8993(01)02619-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

Review 1.  The Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System.

Authors:  Yongjun Sun; Xiaokun Cheng; Linan Zhang; Jie Hu; You Chen; Liying Zhan; Zibin Gao
Journal:  Mol Neurobiol       Date:  2016-01-21       Impact factor: 5.590

2.  S-nitrosylation of c-Src via NMDAR-nNOS module promotes c-Src activation and NR2A phosphorylation in cerebral ischemia/reperfusion.

Authors:  Li-Juan Tang; Chong Li; Shu-Qun Hu; Yong-Ping Wu; Yan-Yan Zong; Chang-Cheng Sun; Fa Zhang; Guang-Yi Zhang
Journal:  Mol Cell Biochem       Date:  2012-03-16       Impact factor: 3.396

3.  Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesis.

Authors:  Jessie E King; Eliseo A Eugenin; Joy E Hazleton; Susan Morgello; Joan W Berman
Journal:  Am J Pathol       Date:  2010-05-06       Impact factor: 4.307

Review 4.  Neuroprotective action of lithium in disorders of the central nervous system.

Authors:  Chi-Tso Chiu; De-Maw Chuang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-06

Review 5.  Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage.

Authors:  Brian Y Hwang; Geoffrey Appelboom; Amit Ayer; Christopher P Kellner; Ivan S Kotchetkov; Paul R Gigante; Raqeeb Haque; Michael Kellner; E Sander Connolly
Journal:  Cerebrovasc Dis       Date:  2010-12-21       Impact factor: 2.762

Review 6.  Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

Authors:  Chi-Tso Chiu; De-Maw Chuang
Journal:  Pharmacol Ther       Date:  2010-08-10       Impact factor: 12.310

7.  Neuroprotection of GluR5-containing kainate receptor activation against ischemic brain injury through decreasing tyrosine phosphorylation of N-methyl-D-aspartate receptors mediated by Src kinase.

Authors:  Jie Xu; Yong Liu; Guang-Yi Zhang
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

8.  Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.

Authors:  Ying Wang; Yansong Li; Shawn L Dalle Lucca; Milomir Simovic; George C Tsokos; Jurandir J Dalle Lucca
Journal:  J Neuroinflammation       Date:  2010-04-09       Impact factor: 8.322

9.  alpha- and gamma-Protocadherins negatively regulate PYK2.

Authors:  Jian Chen; Yanyan Lu; Shuxia Meng; Meng-Hsuan Han; Chengyi Lin; Xiaozhong Wang
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

10.  Beneficial Effects of a CaMKIIα Inhibitor TatCN21 Peptide in Global Cerebral Ischemia.

Authors:  Mohammad Ejaz Ahmed; Yan Dong; Yujiao Lu; Donovan Tucker; Ruimin Wang; Quanguang Zhang
Journal:  J Mol Neurosci       Date:  2016-09-07       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.